Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression*

Histones, and their modifications, are critical components of cellular programming and epigenetic inheritance. Recently, cancer genome sequencing has uncovered driver mutations in chromatin modifying enzymes spurring high interest how such mutations change histone modification patterns. Here, we applied Top-Down mass spectrometry for the characterization of combinatorial modifications (i.e. methylation and acetylation) on full length histone H3 from human cell lines derived from multiple myeloma patients with overexpression of the histone methyltransferase MMSET as the result of a t(4;14) chromosomal translocation. Using the latest in Orbitrap-based technology for clean isolation of isobaric proteoforms containing up to 10 methylations and/or up to two acetylations, we provide extensive characterization of histone H3.1 and H3.3 proteoforms. Differential analysis of modifications by electron-based dissociation recapitulated antagonistic crosstalk between K27 and K36 methylation in H3.1, validating that full-length histone H3 (15 kDa) can be analyzed with site-specific assignments for multiple modifications. It also revealed K36 methylation in H3.3 was affected less by the overexpression of MMSET because of its higher methylation levels in control cells. The co-occurrence of acetylation with a minimum of three methyl groups in H3K9 and H3K27 suggested a hierarchy in the addition of certain modifications. Comparative analysis showed that high levels of MMSET in the myeloma-like cells drove the formation of hypermethyled proteoforms containing H3K36me2 co-existent with the repressive marks H3K9me2/3 and H3K27me2/3. Unique histone proteoforms with such “trivalent hypermethylation” (K9me2/3-K27me2/3-K36me2) were not discovered when H3.1 peptides were analyzed by Bottom-Up. Such disease-correlated proteoforms could link tightly to aberrant transcription programs driving cellular proliferation, and their precise description demonstrates that Top-Down mass spectrometry can now decode crosstalk involving up to three modified sites.

[1]  Albert J R Heck,et al.  Benchmarking multiple fragmentation methods on an orbitrap fusion for top-down phospho-proteoform characterization. , 2015, Analytical chemistry.

[2]  Neil L. Kelleher,et al.  ProSight Lite: Graphical software to analyze top‐down mass spectrometry data , 2015, Proteomics.

[3]  Simone Sidoli,et al.  Bottom-up and middle-down proteomics have comparable accuracies in defining histone post-translational modification relative abundance and stoichiometry. , 2015, Analytical chemistry.

[4]  N. Kelleher,et al.  Analyzing Internal Fragmentation of Electrosprayed Ubiquitin Ions During Beam-Type Collisional Dissociation , 2015, Journal of The American Society for Mass Spectrometry.

[5]  P. Becker,et al.  Global and specific responses of the histone acetylome to systematic perturbation. , 2015, Molecular cell.

[6]  G. Almouzni,et al.  Histone H3 variants and their chaperones during development and disease: contributing to epigenetic control. , 2014, Annual review of cell and developmental biology.

[7]  N. Kelleher,et al.  Site‐specific human histone H3 methylation stability: fast K4me3 turnover , 2014, Proteomics.

[8]  Eugenia G. Giannopoulou,et al.  Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation , 2014, PLoS genetics.

[9]  A. Shilatifard,et al.  Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling , 2014, Science.

[10]  B. Garcia,et al.  Mass spectrometric analysis of histone proteoforms. , 2014, Annual review of analytical chemistry.

[11]  Samuel P. Wein,et al.  Stable-isotope-labeled Histone Peptide Library for Histone Post-translational Modification and Variant Quantification by Mass Spectrometry * , 2014, Molecular & Cellular Proteomics.

[12]  Allan R Brasier,et al.  Multiplexed parallel reaction monitoring targeting histone modifications on the QExactive mass spectrometer. , 2014, Analytical chemistry.

[13]  Jared B Shaw,et al.  The first pilot project of the consortium for top‐down proteomics: A status report , 2014, Proteomics.

[14]  Michael A. Freitas,et al.  Histone H1 Phosphorylation in Breast Cancer , 2014, Journal of proteome research.

[15]  Michael J. Sweredoski,et al.  The top‐down, middle‐down, and bottom‐up mass spectrometry approaches for characterization of histone variants and their post‐translational modifications , 2014, Proteomics.

[16]  M. Stratton,et al.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone , 2013, Nature Genetics.

[17]  Jacob D. Jaffe,et al.  Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia , 2013, Nature Genetics.

[18]  J. Shabanowitz,et al.  Front-end electron transfer dissociation: a new ionization source. , 2013, Analytical chemistry.

[19]  N. Kelleher,et al.  Measurement of acetylation turnover at distinct lysines in human histones identifies long-lived acetylation sites , 2013, Nature Communications.

[20]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[21]  C. Mizzen,et al.  Histone H4 deacetylation facilitates 53BP1 DNA damage signaling and double-strand break repair. , 2013, Journal of molecular cell biology.

[22]  O. Elemento,et al.  EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. , 2013, Cancer cell.

[23]  Murim Choi,et al.  De novo mutations in histone modifying genes in congenital heart disease , 2013, Nature.

[24]  B. Bernstein,et al.  Epigenetic Reprogramming in Cancer , 2013, Science.

[25]  Yang Shi,et al.  Emerging roles for chromatin as a signal integration and storage platform , 2013, Nature Reviews Molecular Cell Biology.

[26]  Oliver Brüstle,et al.  Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies , 2013, Nature Reviews Molecular Cell Biology.

[27]  Peter A. DiMaggio,et al.  Quantitative Dynamics of the Link between Cellular Metabolism and Histone Acetylation , 2013, The Journal of Biological Chemistry.

[28]  H. Schmidt,et al.  Epigenetics and psychostimulant addiction. , 2013, Cold Spring Harbor perspectives in medicine.

[29]  Lloyd M. Smith,et al.  Proteoform: a single term describing protein complexity , 2013, Nature Methods.

[30]  L. Tsai,et al.  Histone acetylation: molecular mnemonics on the chromatin , 2013, Nature Reviews Neuroscience.

[31]  Albert J R Heck,et al.  Toward full peptide sequence coverage by dual fragmentation combining electron-transfer and higher-energy collision dissociation tandem mass spectrometry. , 2012, Analytical chemistry.

[32]  Ronald J Moore,et al.  Enhanced top-down characterization of histone post-translational modifications , 2012, Genome Biology.

[33]  Jonathan D. Licht,et al.  Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3 , 2012, Proceedings of the National Academy of Sciences.

[34]  Jacob D. Jaffe,et al.  Quantitative Assessment of Chromatin Immunoprecipitation Grade Antibodies Directed against Histone Modifications Reveals Patterns of Co-occurring Marks on Histone Protein Molecules* , 2012, Molecular & Cellular Proteomics.

[35]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[36]  E. Wagner,et al.  Understanding the language of Lys36 methylation at histone H3 , 2012, Nature Reviews Molecular Cell Biology.

[37]  D. Patel,et al.  A Poised Chromatin Platform for TGF-β Access to Master Regulators , 2011, Cell.

[38]  B. Garcia,et al.  NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. , 2011, Molecular cell.

[39]  E. Greer,et al.  Transgenerational epigenetic inheritance of longevity in Caenorhabditis elegans , 2011 .

[40]  Timothy J. Durham,et al.  "Systematic" , 1966, Comput. J..

[41]  B. Strahl,et al.  Influence of Combinatorial Histone Modifications on Antibody and Effector Protein Recognition , 2011, Current Biology.

[42]  R. Copeland,et al.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas , 2010, Proceedings of the National Academy of Sciences.

[43]  N. Kelleher,et al.  Histone H1 phosphorylation is associated with transcription by RNA polymerases I and II , 2010, The Journal of cell biology.

[44]  B. Garcia,et al.  In Vivo Residue-specific Histone Methylation Dynamics* , 2009, The Journal of Biological Chemistry.

[45]  D. Reinberg,et al.  The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate , 2009, The Journal of Biological Chemistry.

[46]  Dustin E. Schones,et al.  Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes , 2009, Cell.

[47]  Christodoulos A Floudas,et al.  High Throughput Characterization of Combinatorial Histone Codes* , 2009, Molecular & Cellular Proteomics.

[48]  Kairong Cui,et al.  H3.3/H2A.Z double variant-containing nucleosomes mark ‘nucleosome-free regions’ of active promoters and other regulatory regions in the human genome , 2009, Nature Genetics.

[49]  A. Shilatifard,et al.  An operational definition of epigenetics. , 2009, Genes & development.

[50]  Neil L. Kelleher,et al.  Combinatorial Modification of Human Histone H4 Quantitated by Two-dimensional Liquid Chromatography Coupled with Top Down Mass Spectrometry* , 2008, Journal of Biological Chemistry.

[51]  J. Brumbaugh,et al.  Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[52]  R. Arceci,et al.  The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. , 2008, Blood.

[53]  M. Mann,et al.  Higher-energy C-trap dissociation for peptide modification analysis , 2007, Nature Methods.

[54]  Neil L Kelleher,et al.  Pervasive combinatorial modification of histone H3 in human cells , 2007, Nature Methods.

[55]  Scott A. Busby,et al.  Chemical derivatization of histones for facilitated analysis by mass spectrometry , 2007, Nature Protocols.

[56]  N. Kelleher,et al.  Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4. , 2006, Analytical chemistry.

[57]  Neil L Kelleher,et al.  Mass spectrometric characterization of human histone H3: a bird's eye view. , 2006, Journal of proteome research.

[58]  N. Kelleher,et al.  Gene-specific characterization of human histone H2B by electron capture dissociation. , 2006, Journal of proteome research.

[59]  Neil L Kelleher,et al.  Precise characterization of human histones in the H2A gene family by top down mass spectrometry. , 2006, Journal of proteome research.

[60]  J. Keats,et al.  Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma , 2006, Leukemia & lymphoma.

[61]  J. Shabanowitz,et al.  Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[63]  F. McLafferty,et al.  Activated ion electron capture dissociation for mass spectral sequencing of larger (42 kDa) proteins. , 2000, Analytical chemistry.

[64]  A. Moorman,et al.  WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. , 1998, Human molecular genetics.

[65]  N. Kelleher,et al.  Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies , 2014, Leukemia.

[66]  D. Roote,et al.  Status Report , 2006, Journal of periodontology.